Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland

World News: . []

Presentations related to AFM13 Affimeds lead LINK  bispecific ROCK antibody include a data LINK  of the completed clinical study of AFM13 in combination with LINK  Keytruda pembrolizumab in patients with LINK  or refractory Hodgk in lymp...

More news and information about Affimed N.V.

Published By:

Globe Newswire: 10:30 GMT Wednesday 12th June 2019

Published: .

Search for other references to "affimed" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us